From our humble beginnings
We started with an unsurpassed commitment to help patients tackle their health needs with fresh thinking and novel solutions.
Avion Pharmaceuticals announces the FDA approval and availability of Dhivy® for the treatment of Parkinson’s disease.
Alora acquires Osmotica Pharmaceuticals (Marietta, GA) providing new products to support the Avion Women’s Health division with an acquired pipeline. This acquisition also expands manufacturing capabilities and capacity of Alora Pharmaceuticals.
FDA approval of DHIVY®, a unique carbidopa/levodopa combination product for the treatment of Parkinson’s disease.
Alora acquires Sovereign Pharmaceuticals (Fort Worth, TX). The acquisition expands our product portfolio while integrating manufacturing capabilities with a CMO we already did business with. During that year Alora also expands Sovereign’s CMO footprint, capabilities, and production volume.
Avion Pharmaceuticals announces approval of the first New Drug Application (NDA) in the oral contraceptive category.
Alora acquires and launches a hypothyroidism product and endocrinology sales force. This product was originally developed and launched in 2009.
Acella Pharmaceuticals, LLC, announces approval of a generic Bromfed®, an antihistamine, decongestant, and cough suppressant.
Art Deas is announced as CEO of Alora Pharmaceuticals, the parent company of six specialty pharmaceutical and manufacturing companies.
The Prenate® Vitamin Family, a branded prenatal vitamin line is launched.
Alora establishes a successful track record of commercializing products.
Alora Pharmaceuticals is founded.
“The foundation that makes our company so successful is that we are equally as passionate about our workforce and company culture as we are investing in our communities and providing best-in-class product offerings.”
- Art Deas, Chief Executive Officer
We are uncommon people doing extraordinary things.
At Alora Pharmaceuticals, we strive to make a real-world difference in the lives of patients. Our leadership team brings together a wealth of education and experience, coupled with an unrivaled commitment to pursue new and innovative opportunities with an eye on helping people live healthier lives.
Shannon Faught Chief Commercial Officer
Ben Burgess Senior VP Operations,
Srihari Vedartham Senior VP, Global
Scott Lindler Chief Financial Officer
Allen Fields Executive VP, Clinical & Regulatory Affairs Head of Research & Development
Miguel Gomez Chief Quality Officer
Chris Schwab Executive VP, General
Chris Diton Executive VP, Trade & Account Management
John Spigiel Global Head of Manufacturing & Packaging
We are always upping our game.
At our core, we have an entrepreneurial spirit. Alora Pharmaceuticals and our entire family of companies make real differences in the lives of patients by challenging the status quo with new ideas. Over the years, we have received numerous industry awards and recognition because of this steadfast drive to succeed.
Awards & Recognition
- 2022: Alora Pharmaceuticals Wins Top Pharmaceutical Award – Best of the Best in Healthcare Marketing Honored at Event in NYC on September 23rd
- 2020: Healthcare & Pharmaceutical Awards 2020 – Avion is “the most innovative women’s health pharmaceutical company in the USA”
- 2020 & 2021 & 2022: Avion and Acella Awarded Best Places to Work in Medical Sales
- 2014: Avion Pharmaceuticals, LLC, Awarded HDMA Diana Manufacturer Award